Assignee
AEGIS THERAPEUTICS LLC
US·16 granted patents·18 pending applications·124 citations·filing 2005–2025
Top patents by PatentIndex Score
34 records- 0198US10265402B2Absorption enhancers for drug administrationAEGIS THERAPEUTICS LLC·Filed 2018·Granted Apr 23, 2019·13 cites·7 claims
- 0298US7998927B2Stabilizing alkylglycoside compositions and methods thereofAEGIS THERAPEUTICS LLC·Filed 2008·Granted Aug 16, 2011·38 cites·79 claims
- 0397US11918655B2Intranasal epinephrine formulations and methods for the treatment of diseaseAEGIS THERAPEUTICS LLC·Filed 2023·Granted Mar 5, 2024·5 cites·44 claims
- 0497US11717571B2Intranasal epinephrine formulations and methods for the treatment of diseaseAEGIS THERAPEUTICS LLC·Filed 2022·Granted Aug 8, 2023·6 cites·30 claims
- 0597US11191838B2Intranasal epinephrine formulations and methods for the treatment of diseaseAEGIS THERAPEUTICS LLC·Filed 2020·Granted Dec 7, 2021·8 cites·20 claims
- 0697US10576156B2Compositions for drug administrationAEGIS THERAPEUTICS LLC·Filed 2018·Granted Mar 3, 2020·10 cites·6 claims
- 0796US12324838B2Intranasal epinephrine formulations and methods for the treatment of diseaseAEGIS THERAPEUTICS LLC·Filed 2023·Granted Jun 10, 2025·3 cites·11 claims
- 0896US11744895B2Intranasal epinephrine formulations and methods for the treatment of diseaseAEGIS THERAPEUTICS LLC·Filed 2021·Granted Sep 5, 2023·3 cites·26 claims
- 0996US10682414B2Intranasal epinephrine formulations and methods for the treatment of diseaseAEGIS THERAPEUTICS LLC·Filed 2019·Granted Jun 16, 2020·10 cites·20 claims
- 1095US11173209B2Compositions for drug administrationAEGIS THERAPEUTICS LLC·Filed 2019·Granted Nov 16, 2021·6 cites·10 claims
- 1193US9642913B2Pharmaceutical composition including alkyl glycoside and an anti-seizure agentAEGIS THERAPEUTICS LLC·Filed 2014·Granted May 9, 2017·13 cites·7 claims
- 1292US10046025B2Stabilizing alkylglycoside compositions and methods thereofAEGIS THERAPEUTICS LLC·Filed 2016·Granted Aug 14, 2018·3 cites·18 claims
- 1390US9446134B2Stabilizing alkylglycoside compositions and methods thereofAEGIS THERAPEUTICS LLC·Filed 2014·Granted Sep 20, 2016·4 cites·25 claims
- 1484US9283280B2Compositions for drug administrationAEGIS THERAPEUTICS LLC·Filed 2013·Granted Mar 15, 2016·2 cites·20 claims
- 1583US2025262305A1Intranasal epinephrine formulations and methods for the treatment of diseaseAEGIS THERAPEUTICS LLC·Filed 2025·Application pending·0 cites
- 1677US2026041775A1Compositions for drug administrationAEGIS THERAPEUTICS LLC·Filed 2025·Application pending·0 cites
- 1774US2019209689A1Absorption enhancers for drug administrationAEGIS THERAPEUTICS LLC·Filed 2019·Application pending·0 cites
- 1873US2024197719A1Formulations and methods for the prevention of opioid overdoseAEGIS THERAPEUTICS LLC·Filed 2024·Application pending·0 cites
- 1971US10512694B2Compositions for oral drug administrationAEGIS THERAPEUTICS LLC·Filed 2017·Granted Dec 24, 2019·0 cites·4 claims
- 2071US2021121573A1Absorption enhancers for drug administrationAEGIS THERAPEUTICS LLC·Filed 2020·Application pending·0 cites
- 2170US2018325994A1Anti-bacterial compositions for drug administrationAEGIS THERAPEUTICS LLC·Filed 2018·Application pending·0 cites
- 2266US2017189472A1Anti-bacterial compositions for drug administrationAEGIS THERAPEUTICS LLC·Filed 2017·Application pending·0 cites
- 2363US2024408004A1Compositions, devices, and methods for the treatment of overdose and reward-based disordersAEGIS THERAPEUTICS LLC·Filed 2023·Application pending·0 cites
- 2463US2006046962A1Absorption enhancers for drug administrationAEGIS THERAPEUTICS LLC·Filed 2005·Application pending·0 cites
- 2562US2009326193A1Stabilizing alkylglycoside compositions and methods thereofAEGIS THERAPEUTICS LLC·Filed 2009·Application pending·0 cites
- 2662US2016051624A1Antibacterial compositions for drug administrationAEGIS THERAPEUTICS LLC·Filed 2015·Application pending·0 cites
- 2753US2021220346A1Formulations and methods for the prevention of opioid overdoseAEGIS THERAPEUTICS LLC·Filed 2019·Application pending·0 cites
- 2853US2006046969A1Antibacterial compositions for drug administrationAEGIS THERAPEUTICS LLC·Filed 2005·Application pending·0 cites
- 2953US2020360292A1Oil-soluble drug containing compositions and methods of use thereofAEGIS THERAPEUTICS LLC·Filed 2020·Application pending·0 cites
- 3050US8470370B2Controlled release formulationsAEGIS THERAPEUTICS LLC·Filed 2012·Granted Jun 25, 2013·0 cites·17 claims
- 3148US2013034597A1Orally bioavailable peptide drug compositions and methods thereofAEGIS THERAPEUTICS LLC·Filed 2012·Application pending·0 cites
- 3246US2018000942A1Compositions for drug administrationAEGIS THERAPEUTICS LLC·Filed 2017·Application pending·0 cites
- 3344US2010203014A1Zwitterionic buffered acidic peptide and protein formulationsAEGIS THERAPEUTICS LLC·Filed 2010·Application pending·0 cites
- 3443US2011046058A1Compositions for enteral absorption and sustained action of leptin-related peptides useful in the treatment of obesity and leptin-modulated diseaseAEGIS THERAPEUTICS LLC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when AEGIS THERAPEUTICS LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →